TELO vs TENX

Telomir Pharmaceuticals, Inc. vs Tenax Therapeutics, Inc. — Valuation Comparison 2026

TELO

Biotechnology
Telomir Pharmaceuticals, Inc.
Quality
4.2
out of 10
Value Trap
Price
$1.28
Last close
Models
9/13
Active
VS

TENX

Biotechnology
Tenax Therapeutics, Inc.
Quality
4.5
out of 10
Value Trap
33
LOW
Price
$11.69
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType TELO Fair ValueTELO Upside TENX Fair ValueTENX Upside
Bayesian DCF Intrinsic $0.38 -70.4% $5.58 -52.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.11 -91.4% $4.63 -60.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TELO vs TENX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TELO vs TENX — Which Stock Is More Undervalued?

TENX scores higher with a 4.5/10 quality rating vs TELO's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Telomir Pharmaceuticals, Inc. (TELO) and Tenax Therapeutics, Inc. (TENX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TELO currently trades at $1.28 with a QOC of 4.2/10, while TENX trades at $11.69 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).